Omar Ahmed

American Bar Association provides legal services. It provides law school accreditation, continuing legal education, legal information and other services to assist legal professionals. The firm has members which include judges, court administrators, law professors, and non-practicing attorneys. The company was founded on August 21, 1878 and is headquartered in Chicago, IL.

Chilton Investment Co., Inc. (Chilton) is a SEC-registered investment advisor and hedge fund manager headquartered in Stamford, Connecticut. The firm was founded in 2022 through a corporate reorganization. They are majority owned by Birchwood Investment Co., Inc. Chilton manages the assets of several private investment funds that generally are structured as US limited partnerships or BVI corporations. The firm also manages the investments of one or more private accounts, which generally are established by foundations, endowments, high net worth individuals or families, pension plans, insurance companies or other institutional investors.

Biocomm Square Pty Ltd. provides business development and licensing consulting services. The firm provides business development and licensing, corporate strategy, business planning, project management and portfolio review and technology assessment services. It also offers services like market analysis, competitive intelligence, scientific and commercial evaluation and assessment, in and out licensing strategy development, arrangement and implementation, research collaboration and alliances, biotechnology, biopharmaceuticals and cellular therapeutics services. The company was founded by Andrew John Hubert Gearing and Tsutomu Mori in 2007 and is headquartered in Clayton, Australia.

Goldberg Kohn Ltd. provides legal services. The private company is based in Chicago, IL.

The Association of British Insurers provides insurance services. The non-profit company is based in London, UK. The CEO of the British company is Hannah Gurga.

Novartis Pharma SAS wholesales and distributes pharmaceutical products. It offers generic and branded drugs and medicines. The company is headquartered in Rueil-Malmaison, France.

Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland.

Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.

Black Horse Capital Management LLC (Black Horse) is an independent hedge fund manager headquartered in New York City. Founded in 2002, Black Horse manages the assets of private, wealthy clients.

Topaz Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on developing and commercializing treatments for the pediatric and dermatology markets. Its lead investigational product is a topical cream formulation of ivermectin which is under development. The firm provides medicines for the treatment of head lice, acne and infections, as well as vaccines against childhood diseases. The company was founded by Donald P. Beeman and Nicholas U. Spring in 2005 and is headquartered in Horsham, PA.

The Royal College of General Practitioners is a professional membership body for family doctors in the UK and overseas. The non-profit company is based in London, UK and has subsidiaries in the United Kingdom. The British company is committed to improving patient care and clinical standards. The RCGP offers a fellowship program, which is the highest level of membership and exemplifies their motto "cum scientia caritas". The company also provides accreditation for high-quality resources and activities relevant to general practitioners. The Daffodil Standards is a free, evidence-based framework to help practices self-assess and consistently offer the best end of life and bereavement care. The RCGP represents the interests of established GPs and acts as a conduit for local matters to be raised at national meetings.

Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY.

Pressure Point, Inc. provides health care services. The private company is based in Central Point, OR.

Alcyone Therapeutics, Inc. develops novel treatment modalities for difficult neurological conditions. The company was founded by Paramjith Anand, Adam S. Fleisher, Corey M. McCann, and William L. Olbricht in 2010 and is headquartered in Lowell, MA.

PDS Operating Corp. operates as a biopharmaceutical company. It develops immunotherapies for cancer and infectious disease. The firm’s versamune is capable of potent activation of immune cells without the side effects of traditional vaccines, efficiently delivering disease related antigen targets to the immune system and promoting antigen processing to present antigen appropriately to generate both strong prophylactic and therapeutic immune responses to disease. The company was founded by Frank K. Bedu-Addo and Gregory L. Conn and is headquartered in Princeton, NJ.

Reliefband Technologies LLC designs and develops digital wearable devices that provides therapies for nausea, and morning sickness. The company was founded in 2015 and is headquartered in Horsham, PA.

E. Claiborne Robins Co., Inc. engages in the development, manufacture and marketing of pharmaceutical products. It offers primary care products for treatment of allergy, headache and dermatitis. The company was founded in 1990 and is headquartered in Richmond, VA.

Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023.